Management of pituitary tumours: Strategy for investigation and follow- up

Hormone Research

Volumn 53, Issue SUPPL. 3, 2000, Pages 65-70

  Lissett, C A ^a   Shalet, S M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Endocrine investigations; Management; Pituitary adenomas

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; DOPAMINE RECEPTOR STIMULATING AGENT; GONADOTROPIN; GROWTH HORMONE; HYDROCORTISONE; IMMUNOGLOBULIN; POTASSIUM; PROLACTIN; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE; THYROTROPIN; TUMOR MARKER;

CONFERENCE PAPER; CUSHING DISEASE; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS FUNCTION; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE;

EID: 0033823199     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023537     Document Type: Conference Paper

References (14)

1. Cavaco B, Prazeres S, Santos MA, Sobrinho LG, Leite V: Hyperprolactinemia due to big prolactin is differently detected by commercially available immunoassays. J Endocrinol Invest 1999;22:203-208.
2. Fahie Wilson MN, Soule SG: Macroprolactinaemia: Contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann Clin Biochem 1997;34: 252-258.
3. Bevan JS, Webster J, Burke CW, Scanlon MF: Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 1992;13:220-240.
4. Peacey SR, Toogood AA, Thorner M, Shalet SM: The relationship between 24 hour growth hormone (GH) secretion using an ultrasensitive GH assay, IGF and IGF-BP3 in patients with cured (GH < 5 mU/l) acromegaly. Society for Endocrinology, 189th Meeting. London, Society for Endocrinology, 1998, OC24.
5. Hughes NR, Lissett CA, Shalet SM: Growth hormone status following treatment for Cushing's syndrome. Clin Endocrinol (Oxf) 1999; 51:61-66.
6. Arafah BM, Kailani SH, Nekl KE, Gold RS, Selman WR: Immediate recovery of pituitary function after transsphenoidal resection of pituitary macroadenomas. J Clin Endocrinol Metab 1994;79:348-354.
7. Lees PD, Pickard JD: Hyperprolactinemia, intrasellar pituitary tissue pressure, and the pituitary stalk compression syndrome. J Neurosurg 1987;67:192-196.
8. Arafah BM: Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 1986;62: 1173-1179.
9. Webb SM, Rigla M, Wagner A, Oliver B, Bartumeus F: Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. J Clin Endocrinol Metab 1999;84:3696-3700.
10. Shalet SM, Beardwell CG, Pearson D, Jones PH: The effect of varying doses of cerebral irradiation on growth hormone production in childhood. Clin Endocrinol (Oxf) 1976;5:287-290.
11. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML: Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med 1989;70:145-160.
12. Grossman A, Cohen BL, Charlesworth M, Plowman PN, Rees LH, Wass JA, Jones AE, Besser GM: Treatment of prolactinomas with megavoltage radiotherapy. Br Med J (Clin Res Ed) 1984;288:1105-1109.
13. Gittoes NJ, Bates AS, Tse W, Bullivant B, Sheppard MC, Clayton RN, Stewart PM: Radiotherapy for non-function pituitary tumours. Clin Endocrinol (Oxf) 1998;48:331-337.
14. Turner HE, Vadivale A, Keenan J, Wass JAH: Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation - A follow-up study. Clin Endocrinol (Oxf) 1999;51:281-284.